Episodit
-
About Ezra Melhman:
Ezra Melhman is a seasoned healthcare investor and business leader with a rich background in providing strategic guidance to hospitals, healthcare systems, and healthcare companies. He joined Health Enterprise Partners (HEP) in 2010, as a Managing Partner, bringing with him a wealth of experience in consulting and research services for the healthcare industry.
Before joining HEP, Ezra served as a Senior Analyst at the Advisory Board Company (NASDAQ: ABCO), where he offered best-practice consulting and research services to hospitals and health systems. Following his tenure at the Advisory Board Company, he further honed his expertise as a Senior Consultant at Booz Allen Hamilton, focusing on engagements in the provider space.
Currently, Ezra holds positions on the board of directors of several prominent healthcare companies, including The Intermed Group, Wildflower Health, Kno2, Proven Behavior Solutions, Family First Adolescent Services, and Aware Recovery Care. He has a proven track record of successful board engagements, having previously served on the boards of AxiaMed, Applied Pathways, CenterPointe Behavioral Health System, InDemand Interpreting, Jvion, and Twistle, all of which were acquired by leading healthcare entities.
In addition to his board roles, Ezra contributes to academia as a member of the faculty at Columbia Business School and serves on the Health Policy and Management Executive Council at Harvard School of Public Health. He holds a BA cum laude from Washington University in St. Louis and earned his MBA from Columbia Business School. With his extensive experience and dedication to advancing healthcare, Ezra continues to make significant contributions to the industry.
Things Youâll Learn:
Profitability is now being highly rewarded among healthcare companies.The focus is shifting towards essential technologies and services in the healthcare sector.Stable healthcare services companies are garnering more interest amidst market uncertainties.A surge in M&A activity is anticipated, driven by private equity firms and strategic buyers.Specialization in a specific area can differentiate oneself in the venture capital space.Resources:
Connect with and follow Ezra on LinkedIn.Learn more about Health Enterprise Partners on LinkedIn and their website. -
About Lynne Chou O'Keefe:
Lynne Chou OâKeefe is the Founder and Managing Partner of Define Ventures, an early stage venture capital firm focused on investing in digital health companies redefining healthcare. Define Ventures focuses on incubation, seed, Series A, and Series B-stage digital health startups (www.definevc.com). Lynne has partnered with entrepreneurs to help them build category-defining digital health companies, such as Livongo (NASDAQ: LVGO), HIMS (NASDAQ: HIMS), Unite Us, etc. Previous to Define Ventures, Lynneâs experience includes both healthcare operating, investing, and finance roles. Previously, she was a Senior Partner at Kleiner Perkins, focused on digital health and connected devices early-stage investing. Before joining Kleiner Perkins, Lynne worked at Abbott Vascular and Guidant in multiple roles, launching over ten product families in the US and internationally. Lynne was responsible for building the global commercial strategy and therapy development, as well as playing a key role in the clinical, reimbursement, and operational strategy for these therapies. Earlier in her career, Lynne worked at Apax Partners with a focus on software venture capital investing. In addition, Lynne worked at Goldman Sachs in the Mergers and Acquisitions group and worked on multiple multi-billion dollar acquisitions and sell-side transactions in various industries. Lynne has been named WSJâs Women in Venture Capital to Watch in 2020. Lynne earned a Bachelor of Science degree in Industrial Engineering from Stanford University and an M.B.A. from Harvard Business School.
Things Youâll Learn:
Define Ventures leverages a founder-centric approach to provide strategic insights and partnerships that empower their portfolio companies with an unfair advantage in the digital health market.With $800 million in AUM and partnerships with about 24 companies to date, Define Ventures has become a significant player in the Silicon Valley startup ecosystem, emphasizing strategic insights and a deep understanding of the healthcare industry.It is important to be a supportive and empathetic partner to founders. Define Ventures offers strategic insights and an 'unfair advantage' by leveraging partnerships with providers, payers, and employers to transform the industry and support founders on their journeys.The striking a balance between growth and profitability with portfolio companies and believes the next 48 months will be dynamic for healthcare ventures.Resources:
Connect with and follow Lynne on LinkedIn.Learn more about Define Ventures on their LinkedIn and website. -
Puuttuva jakso?
-
About Scott Barclay:
Scott Barclay is a Managing Director at Insight Partners based in Palo Alto. His Computational Care thesis envisions the future of US and global healthcare built at the intersection of empathy and scalable technology. Scottâs early career traversed capital markets with Banc of America Securities in Europe and the US, The Boston Consulting Group, and CVS Health. At CVS and then after, Scott helped create and scale the nationâs e-prescribing ecosystem, running iScribe (acq Allscripts) and as Chief Strategy Officer of Surescripts. Prior to Insight, Scott built his investing career as a healthcare angel investor and advisor (NaviHealth, Doximity, Elation) and, from 2015 â 2020, as a Partner at DCVC, a world-class early-stage deep tech venture capital firm, where he was a director or observer on the Boards of companies like Carbon Health, Freenome, SafelyYou, and many others.
Things Youâll Learn:
The three big themes that are set to revolutionize healthcare investment.The art and science behind Insight Partners' long-term investment and operational support strategies.Navigating valuation adjustments in turbulent markets and fostering founder relationships.The investment wisdom in an era of market recalibrationâwhat it really takes to write the check.Sustainability and profitability: Scottâs forecast on public exits for health tech startups.Resources:
Connect with and follow Lynne on LinkedIn.Learn more about Insight Partners on their LinkedIn and website. -
About Ian Wijaya:
Ian Wijaya is the Co-Head of Lazardâs North America Healthcare practice. Ian joined Lazard in 2011 and co-founded the Firmâs healthcare services practice, with a focus on M&A, strategic advisory, and recapitalization advisory for managed care insurance payers, providers across the continuum of care (e.g., acute care hospitals, ambulatory surgery centers, post-acute care, etc.), PBMs, distributors, payor and provider services companies, HCIT, and digital health companies.
Ian is a member of Lazardâs Opinion Committee and the World Economic Forumâs Global Future Council on Healthcare, as well as a Corporate Leader on the Council on Foreign Relations.
Ian has advised on more than $250 billion of corporate finance transactions, including mergers and acquisitions, leveraged buyouts, financial restructurings and reorganizations, joint ventures, and other matters, and has advised on several of the largest and most transformative M&A transactions in healthcare, including three of the largest in recent history.
Prior to joining Lazard, Ian was an investment banker at Greenhill & Co. in New York, where he focused on healthcare M&A but also provided M&A advice to companies in the technology and retail sectors. Prior to Greenhill & Co., he worked in the Investment Banking Division of Goldman Sachs & Co. and the financial restructuring group of Houlihan Lokey in New York.
Ian has an M.B.A. in Finance and Strategy from Northwestern Universityâs Kellogg School of Management and a B.A. (cum laude) from Dartmouth College.
Things Youâll Learn:
The candid examination of market barriers and what it takes to finalize deals in turbulent times.The healthcare tech market demands investments in businesses with sustainable unit economics and the potential for operating leverage, promoting a balance between profit and growth.Strategic buyers and private equity are looking for healthcare services that can enhance supply chain visibility, manage costs efficiently, and improve patient outcomes through tech-enabled solutions.AI stands poised to revolutionize healthcare across several domains, with an emphasis on clinical decision support, population health management, and automation of administrative tasks.AI in healthcare will likely boom in 3 areas: clinical support, population health management, and operational automation.Resources:
Connect with and follow Ian Wijaya on LinkedIn.Learn more about Lazard on their LinkedIn and website. -
About Omkar Kulkarni:
Omkar P. Kulkarni is the first chief innovation officer at Childrenâs Hospital Los Angeles. In his role, Kulkarni is responsible for fostering innovation across Childrenâs Hospital Los Angeles's clinical and research enterprises â including launching an enterprise virtual care program, incubating and implementing new digital health tools and medical devices, and rallying communities inside and outside of the hospital to solve problems in the field of pediatrics â all with the goal of enhancing the experience and outcomes for the children and families Childrenâs Hospital Los Angeles serves. Kulkarni is also the founder and managing director of KidsX, a consortium-based digital health accelerator that is comprised of over fifteen leading pediatric hospitals from around the world.
Prior to joining Childrenâs Hospital Los Angeles, Kulkarni served as executive director of the Cedars-Sinai Accelerator powered by Techstars, where he helped build and launch the accelerator program. In that role, he evaluated over 3,000 healthcare start-ups and provided extensive mentoring, serving as the main liaison between the start-up community and Cedars-Sinai Medical Center. Kulkarni also led the performance improvement department at Cedars-Sinai for many years and has experience in financial process redesign at NewYork-Presbyterian Hospital. Kulkarni has a masterâs degree in public health and health care management from Columbia University and a bachelorâs degree in business administration from George Washington University.
Things Youâll Learn:
AI can predict patient no-shows and optimize scheduling, freeing up crucial appointment slots and ensuring resources are optimally allocated.Adopting new solutions not only streamlines processes but boosts staff engagement and patient satisfaction by refocusing skilled labor on patient care rather than auxiliary tasks.Beyond financial health, measuring access, clinical outcomes, and patient/family engagement provides a more comprehensive view of organizational success.The challenge of serving a diverse, multilingual patient population, many of whom are under the poverty line.How CHLA manages to provide top-tier clinical care, groundbreaking research, and education, all while "defying gravity" in the face of financial struggles.Resources:
Connect with and follow Omkar Kulkarni on LinkedIn.Learn more about Children's Hospital Los Angeles on their LinkedIn and website. -
About Dr. Eve Cunningham:
Eve Cunningham, MD MBA, the Chief of Virtual Care and Digital Health at Providence, and an active member of the HIMSS community. Throughout her career, she's balanced surgical skills as a gynecologist with incubating and scaling digital assistant products for providers at Providence.
Balancing career with spouse and three children has been her biggest challenge. She advises working mothers to customize their balance based on beliefs, resources, and support. As a leader, she's sensitive to her team's challenges, balancing work and life.
Her future challenge is navigating healthcare transformation and integrating AI/ML technology into clinical workflows, advocating for clinician involvement to ensure responsible use.
Cunningham believes the future of health information and technology for women is bright, with more entering the field and changing gender ratios emphasizing value and competency.
Motivated by mentorship, she resonates with Steve Jobs' quotes on teamwork and revolutionary change. Cunningham is proud to serve on HIMSS committees and recently participated in the CMIO Panel at HIMSS22, focusing on innovations to address burnout and administrative burden.
Things Youâll Learn:
Innovation in healthcare is not just about technology; it's about solving real challenges like workforce shortages and care fragmentation.Virtual care isn't just for minor issues; it spans from primary care to post-acute services, improving access and outcomes.Omnichannel healthcare aims to provide seamless care across different platforms, but regulatory hurdles and privacy concerns remain significant barriers.Collaboration between clinicians and tech experts is essential for meaningful innovation in healthcare.Successful healthcare transformation requires a holistic approach, considering both clinical outcomes and financial sustainability.Resources:
Connect with and follow Eve on LinkedIn.Learn more about Providence on LinkedIn and their website. -
About Ken Washington:
Ken Washington serves as the Senior Vice President and Chief Technology and Innovation Officer at Medtronic, leading the charge in accelerating innovation through strategic product development and technology initiatives. With a wealth of experience spanning various industries including robotics, consumer products, automotive, and space, Ken joined Medtronic in 2023, bringing deep expertise in technology development and execution.
As a visionary leader, Ken inspires and motivates teams to push the boundaries of invention and innovation, driving positive market disruptions. He collaborates closely with teams and leaders across Medtronic to ensure the continuous advancement of products and therapies in alignment with the company's mission to better serve patients and customers.
Prior to his role at Medtronic, Ken held notable positions including Vice President and General Manager of Consumer Robotics at Amazon and Chief Technology Officer at Ford Motor Company, where he oversaw the development of technology strategies and next-generation vehicle architectures. With seven years at Lockheed Martin, Ken held various leadership roles, including Chief Technology Officer and Vice President of the Advanced Technology Center.
Ken is internationally recognized as a thought leader in technology and innovation, with accolades including induction into the National Academy of Engineering in 2020 and the Black Engineer Hall of Fame in 2023. He holds a Bachelor of Science, a Master of Science, and a PhD in nuclear engineering from Texas A&M University.
Things Youâll Learn:
Medtronic impacts two patients every second, showcasing the scale of their influence in healthcare.Innovation is key for Medtronic, as they continuously strive to engineer the extraordinary.Staying focused on its mission helps Medtronic differentiate its products in a competitive market.Medtronic's AI Center of Excellence accelerates the development of AI-enabled therapies for better patient care.Medtronic's mission is to alleviate pain, restore health, and extend life through innovative therapies.Resources:
Connect with and follow Ken on LinkedIn.Learn more about Medtronic on LinkedIn and their website.Discover more about Medtronicâs GI Genius here. -
About Max Cohen:
Max Cohen serves as the CEO and Co-founder of Sprinter Health, headquartered in California. The company deploys W-2 employees, dubbed "Sprinters," equipped with the medical assistant, phlebotomy, and Community Health Worker expertise, directly into households to engage patient populations that may otherwise be disengaged. Sprinter collaborates with health plans and health systems, offering preventive services with no copay or deductible. Prior to launching Sprinter Health, Max held the position of VP of Mobile at Oculus, and following the acquisition by Facebook continued to oversee various initiatives including Mobile VR, Mobile and Platform Products, and Media. Before his tenure at Oculus, Max contributed to the Product team at Google in Los Angeles and gained experience at McKinsey and Company, as well as Lockheed Martin's Skunk Works. Max holds a BSE in Electrical Engineering and a BS in Physics from Duke University, supplemented by an MBA from Harvard Business School.
Things Youâll Learn:
Sprinter Health revolutionizes healthcare delivery by deploying W-2 "Sprinters" with diverse medical skills into homes, targeting under-engaged patient populations and bridging care gaps.By partnering directly with health plans and systems, Sprinter Health offers preventive services with no financial barriers, promoting accessibility and proactive care.Max Cohen's background at Oculus and Google informs Sprinter Health's innovative approach, prioritizing patient engagement and efficient execution.Sprinter Health's commitment to quality care is reflected in its high patient satisfaction ratings, demonstrating the effectiveness of in-home healthcare solutions.Strategic expansion plans aim to maximize market impact by prioritizing regions with existing business partnerships and potential for growth.Resources:
Connect with and follow Max Cohen on LinkedIn.Learn more about Sprinter Health on LinkedIn and their website. -
About Yuechen Zhao :
Yuechen is a Partner at GSR Ventures, where he focuses on early-stage investments in enterprise software and consumer platforms. Prior to GSR Ventures, Yuechen founded a personalized travel startup and built products at Google, Uber, and Meixin (fintech). Yuechen received his BA in Computer Science from Harvard University.
Things Youâll Learn:
Despite public and private market fluctuations, a steady, long-view approach in investment strategy remains central, with a focus on substantive innovations with enduring value.Emerging AI technologies offer transformative potential in healthcare accessibility and patient empowerment.Successful investing is anchored in a decade-long commitment and the intimate support between founders and investors that goes beyond mere financial transactions.As investment climates shift and the health tech scene faces valuation declines, GSR Ventures strategizes to remain steadfast, resourceful, and committed to its portfolio companies.Entrepreneurs need market momentum and passion for problem-solving to sustainable business models that promise scalability and defensibility.Resources:
Connect with and follow Yuechen Zhao on LinkedIn.Learn more about GSR Ventures on their LinkedIn and website. -
About Novlet Mattis :
Novlet Mattis, Senior Vice President, Chief Digital and Information Officer, As Orlando Healthâs chief digital and information officer, Novlet provides executive leadership for information technology, digital capability supply chain, and systems that advance clinical and business strategies, digitally engage patients, providers, and businesses, and optimize operational processes.
Before joining Orlando Health in 2018, she was with Ascension Health in St. Louis, where she served as vice president of information technology, supporting more than 125 hospitals across the U.S. and international joint ventures.
Novlet was also vice president of IT and chief information officer at UNC Rex Healthcare in Raleigh, North Carolina, and has held leadership positions at Dell Global Services, Lucent Technologies, and AT&T.
She earned a bachelorâs in business administration from Howard University and an MBA from George Washington University, both in Washington, D.C. She is a Certified Healthcare CIO through the College of Healthcare Information Management Executives (CHIME).
Things Youâll Learn:
Orlando Health strikes a crucial balance between managing finances and innovating, particularly by adopting a unified EMR system and ventures into AI to improve patient care.The organization is not just expanding its physical footprint but also investing in data and digital platforms for future growth. Orlando Healthâs response to COVID-19 and push towards digital innovations like virtual sitters demonstrate resilience and forward thinking. By centralizing their data, the organization is paving the way to monetize information while ensuring enhanced patient care.Orlando Health stands out because of physician loyalty, strong economies, and unparalleled patient care.Resources:
Connect with and follow Novlet Mattis on LinkedIn.Learn more about Orlando Health on their LinkedIn and website. -
About Jayme Strauss:
Jayme Strauss is the Chief Clinical Officer of Viz.ai. Jayme has over 10 years of experience as a healthcare executive building clinical service lines in the areas of Neuroscience and Oncology. Jayme previously was the Executive Director of Neuroscience at Piedmont Healthcare in Georgia and Assistant Vice President of Neuroscience and Oncology at Baptist Health South Florida. Jayme is passionate about evolving the way that healthcare is delivered globally, ensuring patients have access to life-saving therapies, and moving science forward through research.
Things Youâll Learn:
Leveraging a wealth of healthcare data, AI is applied by Viz.ai to enhance early patient identification for treatment, potentially revolutionizing patient outcomes, specifically in stroke care and cardiac monitoring.Commitment to rigorous clinical evidence and real-world application signifies an impactful step away from AI speculation to tangible, measurable improvements, demonstrating decreased hospital stays and faster treatment times by Viz.ai.Successfully navigating complex healthcare systems to deliver personalized, impactful AI solutions, Viz.ai intricately involves diverse care teams in product design and focuses on scalability.Engaging with everyone from physicians to clinic schedulers, tailored AI tools addressing the intricate needs of patient care are created by Viz.ai.Getting through to the complex web of healthcare stakeholders isn't easy, and that's where Viz.aiâs bespoke solutions shine.Resources:
Connect with and follow Jayme Strauss on LinkedIn.Learn more about Viz.ai on their LinkedIn and website. -
Historically, the FDA was used to approving material health products and medical devices.
But with the rise of health technology, including generative AI, the department must approach regulations differently to ensure that digital products remain safe and effective once theyâre on the market.
So, how does the FDA think about monitoring digital health products and diagnostics? How do they assess the risks associated with innovations in the healthcare space?
Troy Tazbaz is Director of the Digital Health Center of Excellence at the FDA, where he's responsible for envisioning a future of safe and effective healthcare delivery with a focus on advancing public health goals with the use of technology.
On this episode of The Beat, Troy joins hosts Dr. Jessica Shepherd and Dr. Gautam Gulati to discuss the role of the FDA in the regulatory oversight and safety of digital health products and diagnostics.
Troy explains how losing his wife to cancer informs his work and shares the risk management framework the FDA uses to keep up with the speed of health innovation.
Listen in for Troyâs insight on prioritizing technology that addresses labor shortages that delay care and learn how the FDA develops policy around emerging technologies in healthcare.
Topics Covered
Troyâs 4 areas of focus as Director of Digital Health at the FDAHow losing his wife to cancer informs Troyâs approach to innovation and regulations in healthcareHow not being a doctor or lawyer gives Troy a different perspective on digital health regulationsThe risk management framework the FDA uses to keep up with the speed of innovationWhy itâs the health systemâs decision whether to integrate digital health products based on the level of risk theyâre comfortable with How Troy thinks about mental health concerns that might arise from generative AI productsPrioritizing technology that addresses labor shortages that delay careWho should be responsible for identifying when things go wrong in digital health productsThe potential to exacerbate the digital divide when health systems must monitor digital health products and diagnostics on their ownWhy prevention is the best way to deal with chronic conditionsWhat Troy is most excited about when it comes to innovation in healthcareWhat federal agencies can do to build trust with the publicConnect with Troy Tazbaz
FDA Digital Health Center of ExcellenceTroy on LinkedInConnect with Dr. Gautam Gulati & Dr. Jessica Shepherd
ViVEHLTHDr. Shepherd on TwitterDr. Shepherd on LinkedInDr. Gulati on TwitterDr. Gulati on LinkedInResources
The Continuum Diaries -
About Maneesh Goyal:
Maneesh leads operations, strategy, and financial performance for Mayo Clinic's Platform initiative
He brings a cross-disciplinary background in finance, investing, product development and engineering. Prior to joining Welltok, Maneesh was a Managing Director with Miramar Venture Partners, a leading early-stage investor focusing on the information technology space. With Miramar, Maneesh led investments and was an advisor and board member for several health and consumer Internet companies. Before entering the venture world, Maneesh was an early employee with Broadcom, a Fortune 500 Company, leading product development and engineering efforts in more than a dozen communications technology solutions.
Maneesh earned a bachelorâs degree in biomedical engineering from Worcester Polytechnic Institute, a masterâs in electrical engineering from the University of Southern California, and an MBA from the Anderson School of Management at UCLA.
Things Youâll Learn:
AI is utilized for early disease detection and precision medicine, revolutionizing patient outcomes while significantly reducing costs compared to traditional methods.The Mayo Clinic Platform integrates technology to facilitate a seamless convergence of providers, innovators, and healthcare institutions, emphasizing its holistic approach beyond mere technological advancements.Mayo Clinic's collaborations drive healthcare progress, facilitating global accessibility to clinically validated tools and highlighting their dedication to integrated medicine.The Mayo Clinic platform seeks to overhaul the healthcare system, aiming for reduced infection risks and more efficient home care, thereby modernizing hospitals that have remained largely unchanged for 150 years.Through seamless partnerships, the Mayo Clinic platform utilizes technology to deliver healthcare services in unprecedented ways, prioritizing innovation and efficiency.Resources:
Connect with and follow Maneesh Goyal on LinkedIn.Follow the Mayo Clinic on LinkedIn and visit their website. -
What are patients looking for in a health care provider?
Zocdoc has been in business for 17 years, and in that time, the platform has collected a significant amount of data regarding what patients want from their health care.
And you may be surprised to learn what matters most to consumers in the process of choosing a provider, be it a primary care doctor or specialist.
Dr. Oliver Kharraz is Founder and CEO of Zocdoc, the leading healthcare marketplace in the US. Millions of patients visit Zocdoc monthly to find quality, in-network doctors and book appointments for in-person or virtual care.
In his wide-ranging career, Dr. Kharraz has gained comprehensive experience in building efficiency and affecting change in large scale health organizations using information technology.
On this episode of The Beat, Dr. Kharraz joins host Dr. Gautam Gulati to discuss the latest research and insights on patient and physician engagement from Zocdocâs 2023 Report: What Patients Want.
Dr. Kharraz discusses the pros and cons of offering patients a suite of choices for access to care and shares Zocdocâs guided search experience for selecting the right provider.
Listen in to understand how Zocdoc uses machine learning and AI to serve consumers and clinicians and learn the top three things patients consider as they choose a health care provider.
Topics Covered
The pros and cons of offering a suite of choices for patients to access careHow often Zocdoc patients go back to the same provider (once the initial choice is made)How Zocdoc functions as the interoperability layer for logistics in the healthcare systemCategorizing the different types of access to care from a patientâs perspectiveHealthcare technologies that the consumer isnât ready for vs. healthcare technologies that havenât figured out their business modelZocdocâs guided search experience for choosing between telehealth and in-person visitsThe challenges Zocdoc faces in publishing prices for different care optionsHow Zodoc uses machine learning and AI to serve consumers and cliniciansDr. Kharrazâs vision for using the blockchain to solve for trust in healthcare informationDr. Kharrazâs top 3 key takeaways from Zocdocâs What Patients Want ReportWhy the needle hasnât moved on the primary issues in healthcare despite significant advancements in technologyConnect with Dr. Oliver Kharraz
Dr. Kharraz at ZocdocDr. Kharraz on LinkedInConnect with Dr. Gautam Gulati & Dr. Jessica Shepherd
ViVEHLTHDr. Shepherd on TwitterDr. Shepherd on LinkedInDr. Gulati on TwitterDr. Gulati on LinkedInResources
Zocdoc Practice SolutionsZocdoc 2023 Report on What Patients WantAtul Gawandeâs 2017 Piece on Incremental Care -
We know that diverse founders only receive a fraction of VC funding. And that healthcare inequality is exacerbated by the lack of diverse perspectives and solutions in healthcare tech.
But what if there was a venture fund that focused on diverse founders building healthcare technology for the communities they come from?
Justin Williams is Principal at Seae Ventures, an investment firm specializing in early-stage healthcare technology companies founded by diverse entrepreneurs.
In his role at Seae, Justin leads portfolio sourcing, deal due diligence, financial modeling and portfolio management.
On this episode of The Beat, Justin joins host Dr. Jessica Shepherd to discuss healthcare portfolios that focus on diversity and disadvantaged communities.
Justin shares examples of Seaeâs portfolio companies, explaining how Functional Fluidics serves patients with sickle cell disease and Kiyatec helps cancer patients make personalized therapy decisions.
Listen in for insight on implementing new innovations in diverse patient populations and learn how Seae is moving the needle on health equity by investing in diverse founders of healthcare tech.
Topics Covered
What inspired Justinâs transition from finance to healthcare investingHow its mission to advance equity through opportunity drew Justin to SeaeHow Functional Fluidics serves patients with sickle cell diseaseThe benefit of founders being a part of the communities they serveJustinâs passion for investing in diverse founders who help underserved communitiesHow Kiyatec helps cancer patients make personalized treatment decisionsIdentifying how certain communities, ethnicities and genders respond to cancer therapiesSeaeâs strategies for finding new portfolio companiesThe diversity among Seaeâs team and the companyâs group of foundersHow Seae works with FQHCs to implement tech solutions in diverse patient populationsJustinâs advice for aspiring VCs from diverse communitiesConnect with Justin Williams
Seae VenturesJustin on LinkedInConnect with Dr. Gautam Gulati & Dr. Jessica Shepherd
ViVEHLTHDr. Shepherd on TwitterDr. Shepherd on LinkedInDr. Gulati on TwitterDr. Gulati on LinkedInResources
Functional FluidicsKiyatecSeaeâs Partnership with EBNHC -
About Russ Richmond:
Russ Richmond has diverse work experience spanning various industries and roles. Russ is the CEO and Co-founder of Laudio, a healthcare leadership company that improves frontline actions. Russ has also served as a Member of the Innovation Growth Board at Mass General Brigham. In addition, they have held positions such as Executive Chairman and Independent Board Director at Validic, Member of the Board of Directors at BioDigital, and CEO and Board Director at Advanced Practice Strategies (APS), where they successfully restructured the company and facilitated its acquisition. Russ has also worked at Explorys, an IBM company, as an Independent Board Director. Prior to that, they were the CEO and co-founder of Objective Health, a startup within McKinsey & Company, where they played a significant role in establishing the company and leading its performance insights efforts. Russ had earlier worked as a Consultant and Associate Principal at McKinsey & Company. Russ also has experience as the Executive Vice President of Verisk Health and as a resident physician at the University of Michigan Health System.
Things Youâll Learn:
Laudio redefines healthcare management by empowering frontline leaders with integrated, AI-powered workflows, addressing issues like burnout and turnover.Laudio's strategy of publishing data-driven insights fosters a culture of informed leadership and drives the spread of Laudio's solutions.Laudio accelerates market adoption despite the typically slow healthcare sales cycle, building a teamwork-based approach to engage multiple executive stakeholders for impactful collaboration.The platform's AI-driven approach to automating managerial tasks can save up to 6 hours a week for health managers. The strategies that Laudio employs to foster customer acquisition, scaling effectively in an industry known for long sales cycles.Resources:
Connect with and follow Dr. Russ Richmond on LinkedIn.Follow Laudio on LinkedIn and visit their website. -
About Nasim Afsar:
Nasim Afsar is relentlessly focused on advancing the health and care of the world through Healthy People, Healthy Workforce, and Healthy Business. As Chief Health Officer, Dr. Afsar leads Product Strategy, Global Market Strategy, and Entry and Third Party Partnerships. Last year, her team delivered higher quality care for over 2 million people (Healthy People), saved physicians and nurses nearly 200,000 hours (Healthy Workforce), and positively impacted the financial performance of clients (Healthy Business). She leads Oracle Healthâs Steering Committees on AI/ML in Healthcare, Retail in Healthcare, and Payers. Her team has a focus on health equity, working closely with key stakeholders globally. She also works on building the larger ecosystem of healthcare, including working closely with payers, retail, pharma food and beverage, and public health agencies.
Previously, Dr. Afsar served as Chief Operating Officer for UCI (University of California, Irvine) Health. She led inpatient and ambulatory operations, including ambulatory care, inpatient progression efforts, clinical support services, ancillary services, public safety, building and construction, and emergency management. She led health system contracting, working closely with payers to bring new products to market. Her work led to historically high ambulatory growth, inpatient volumes, surgeries, and tertiary care transfers to the institution. During her tenure at UCI Health, Dr. Afsar spearheaded and co-led innovative programs, such as telehealth, hospital-at-home, and strategic partnerships, to help provide value for patients and communities. After the onset of COVID-19, Dr. Afsar created a mobile field hospital, led the licensure of ambulatory spaces, created drive-thru COVID-19 testing centers, and led a large-scale COVID-19 vaccination program.
Things Youâll Learn:
Oracle Health is committed to advancing healthcare by combining best-in-class technology with clinical, operational, and financial outcomes.The potential of Oracle's health data intelligence platform is groundbreaking as it brings together various healthcare entities.Oracle integrates data from numerous sources and applies intelligence to potentially lost data crucial for precision medicine.Oracle's aim is to empower healthcare providers in different roles.Current digital innovations should be designed to reduce administrative burden and enhance decision-making processes for healthcare providers, ultimately enriching patient care and potentially revolutionizing the industry.Resources:
Connect with and follow Nasim Afsar on LinkedIn.Follow Oracle on LinkedIn and visit their website. -
In 2009, David Goldhillâs father died of a hospital-acquired infection. And he realized that preventing medical errors was not an economic imperative in the American healthcare system.
In fact, our third-party payment system creates a misalignment of incentives, making insurers and governments the customer rather than the patients themselves.
So, David wrote a cover story for The Atlantic entitled âHow American Health Care Killed My Fatherâ which expanded into a book, Catastrophic Care: Why Everything We Think We Know about Health Care Is Wrong.
Since then, David has become a leading voice for healthcare advocacy and founded Sesame, a company that is revolutionizing healthcare with a direct-pay marketplace that delivers high quality healthcare at half the price.
On this episode of The Beat, David joins hosts Dr. Jessica Shepherd and Dr. Gautam Gulati to explain who uses the marketplace and how competition drives down prices on Sesame without compromising quality of care.
David discusses what attracts providers to the Sesame model and describes the criteria for joining the platform as well as its rigorous rating system.
Listen in for insight on maintaining continuity of care in telehealth and learn how David is bringing a revolution of consumerism to healthcare in the US and around the world.
Topics Covered
How Sesame eliminates the third-party payment system from healthcareThe breakdown of who uses Sesameâs direct pay marketplaceHow competition drives down prices on Sesame without compromising quality of careThe personal experience that inspired Davidâs healthcare advocacyHow the third-party payment system causes a misalignment of incentives in healthcareWhy insurance- and safety net-based healthcare systems are outdated What attracts healthcare providers to the Sesame modelThe criteria for providers to join Sesame and the platformâs rigorous rating systemHow David thinks about maintaining continuity of care in telehealthHow Sesame handles the transference of health records and informationWhat David admires about the current healthcare system in AmericaDavidâs vision for bringing a revolution of consumerism to the healthcare industryConnect with David Goldhill
SesameDavid at SesameDavid on LinkedInConnect with Dr. Gautam Gulati & Dr. Jessica Shepherd
ViVEHLTHDr. Shepherd on TwitterDr. Shepherd on LinkedInDr. Gulati on TwitterDr. Gulati on LinkedInResources
âHow American Health Care Killed My Fatherâ in The AtlanticCatastrophic Care: Why Everything We Think We Know about Health Care Is Wrong by David GoldhillAtul GawandeâThe Cost Conundrumâ in The New YorkerâThe Heroism of Incremental Careâ in The New YorkerâIn Health Care, America Is the Worldâs Indispensable Nationâ in The Washington Post -
WebMD is the most trusted online platform for health education. But as we know, information does not equal transformation.
So, how do we engage people throughout their health journey? How do we encourage them to apply what theyâve learned about good health and implement the behavior changes necessary for long-term health?
Can AI and other emerging technologies support this kind of patient engagement?
Dr. John Whyte is Chief Medical Officer at WebMD, where he leads the development of strategic partnerships that create meaningful change around important public health issues.
Dr. Whyte has written extensively, creating award-winning health content for TV and the web, and developed numerous initiatives addressing diversity in clinical trials.
On this episode of The Beat, Dr. Whyte joins hosts Dr. Jessica Shepherd and Dr. Gautam Gulati to discuss how WebMD has evolved over the last 27 years and describe WebMD Igniteâs solutions for engaging patients throughout their healthcare journey.
Dr. Whyte shares his vision for democratizing access to health technology tools and resourcesâand then using that personalized data to provide better care.
Listen in for insight on connecting good habits with independent living later in life and learn how to bridge the gap between health information and habit change for long-term health transformation.
Topics Covered
Why WebMD is the most trusted online platform for health educationHow WebMD has evolved in its aim of empowering people with information over 27 yearsWhat physicians can do to engage with patients whoâve done their own health researchWebMD Igniteâs solutions for every stage of the healthcare journeyLeveraging technology to engage patients and reduce healthcare disparitiesInnovating around existing behaviors vs. trying to get patients to change their behaviorDr. Whyteâs vision for democratizing access to health technology tools and resources (and then using that personalized data to provide better care)Strategies for engaging patients and encouraging incremental habit changeHow our systems reinforce bad behavior in the context of healthDr. Gulatiâs future press release exercise of inspiring people to focus on their healthConnecting simple exercises with independent living later in lifeConnect with Dr. John Whyte
Dr. Whyte at WebMDDr. Whyteâs WebsiteConnect with Dr. Gautam Gulati & Dr. Jessica Shepherd
ViVEHLTHDr. Shepherd on TwitterDr. Shepherd on LinkedInDr. Gulati on TwitterDr. Gulati on LinkedInResources
MedscapeWebMD IgniteSame as Ever by Morgan HouselHara Hachi Bu -
Did you know that there is a team of techies who serve the Centers for Medicare & Medicaid Services or CMS?
What is their role in this federal agency? How is CMS changing with emerging technologies?
And how might software engineers, project managers and other tech professionals help innovate from the inside to reform the complicated healthcare system in the US?
Andrea Fletcher is the first Chief Digital Strategy Officer and Executive Director of Digital Services at CMS, where she is responsible for leading digital modernization efforts and promoting interoperability and public access to health data.
On this episode of The Beat, Andrea joins hosts Dr. Jessica Shepherd and Dr. Gautam Gulati to explain how her team responds to tech emergencies and plans big strategic plays for CMS.
Andrea discusses the potential for the federal government to be a leader in AI adoption and shares her open-source software initiative to reuse tech stacks within and across federal departments and agencies.
Listen in for Andreaâs insight on leveraging data to rethink how we pay for and deliver care and learn how CMS is looking to evolve with âJetsonâs eraâ technologies and improve the experience of healthcare for individual Americans.
Topics Covered
What Andreaâs team of techies does as the Digital Service at CMSHow Andreaâs team responds to tech emergencies and plans big strategic plays for the agencyHow Andreaâs team collaborates with other federal departments and agenciesAndreaâs hope that the federal government will be a leader in the adoption AI (and what that might look like)What differentiates leading in government from the private sectorOpportunities to innovate within the complicated Medicare and Medicaid systemsAndreaâs open-source software initiative to reuse tech stacks across federal departments and agenciesAndreaâs human-centered approach to leveraging AI in healthcare Rethinking how we pay for and deliver care in a world of advanced technologyWhat we can learn from the VAâs diabetes prevention research and outcomes-based care modelAndreaâs predictions re: how clinics will change in the future and what roles AI might replaceHow to participate in shaping Americansâ healthcare experienceConnect with Andrea Fletcher
The Digital Service at CMSAndrea at CMSAndrea on LinkedInConnect with Dr. Gautam Gulati & Dr. Jessica Shepherd
ViVEHLTHDr. Shepherd on TwitterDr. Shepherd on LinkedInDr. Gulati on TwitterDr. Gulati on LinkedInResources
US Digital ServiceFindSupport.govWhite House Initiative on Womenâs Health ResearchCybersecurity & Infrastructure Security AgencyVA Research on DiabetesDigitalVA - Näytä enemmän
